ESG Report 2022

5.3.2 Privacy Protection In the process of business operation, the Group's has created a mobile office platform system, employees of various departments will be in contact namely “Smart United Laboratories”. The system with different personal information such as integrates a variety of functions. Among them, big information of customers, shareholders, employees data management allows data utilization and and employment candidates, thus there is a risk of analysis to be mobilized and fully popularized personal information and privacy leakage. In order among staff. The patient data micro-file system to reduce the relevant risks, the Group has effectively strengthens patient data management, formulated The United Laboratories Patient making it easier for customers to pay return visits Information Protection System and The United and use information more securely. The Group's Laboratories Information Confidentiality System to Information Centre will manage and maintain the ensure the Group legally obtains and uses personal platform system and take different management information, protects the legal rights and interests measures to prevent leakage or destruction of of information providers, as well as prevents the patient information, such as managing access risks incurred from improper management of rights for patient information personnel, and personal information. The system has regulated the strengthening network security to prevent cyber methods on collection, use, transmission and virus attacks and intrusion of personal information storage of personal information, lowered the risks database. Patient information is stored in the of employees violating relevant laws when platform system according to the length of after- processing personal information, and avoided sales service and expired information will be bringing negative impacts to stakeholders. destroyed by the Marketing Department, in which the process is monitored and documented by In order to improve the efficiency and effectiveness dedicated personnel. of patients' information management, the Group The Group has made continual breakthroughs in United Laboratories Methods of Intellectual the research and development of pharmaceuticals Property Management in accordance with relevant and innovative production technologies, and laws and regulations to regulate the patent therefore the protection of our commodities' application and maintenance work. For new patents and intellectual property rights has become technologies, new processes, new formulas, utility an indispensable part of the protection of our models and product packaging designs, the Group products and assets. In order to promote the will carry out comprehensive patent rights Group's management of intellectual property rights application and maintenance to create favourable and to fully develop the benefits of patented conditions for the Group's research, development commodities and assets, we have formulated The and innovation. 5.4 Protection of Intellectual Property Rights Patent Law of the People's Republic of China Trademark Law of the People's Republic of China Copyright Law of the People's Republic of China Anti-Unfair Competition Law of the People's Republic of China Intellectual Property Management The Intellectual Property Department is While protecting the Group's own intellectual responsible for the management of intellectual property rights, we never infringe the copyrights of property, application and management of patents the commodities of other individuals or enterprises. and intellectual property logos, supervision of The establishment of the Intellectual Property related units in stopping, reporting and obtaining Affairs Department has strengthened the protection evidence for the various infringement behaviours of the Group's technology, process, formulation found, as well as the coordination with the and other patented technologies. government in combating infringement behaviours. Relevant Laws Regulations and Realm Environmental, Social and Governance Report 2022 The United Laboratories International Holdings Limited 25